These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2206973)

  • 21. Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis.
    Maza A; Montaudié H; Sbidian E; Gallini A; Aractingi S; Aubin F; Bachelez H; Cribier B; Joly P; Jullien D; Le Maître M; Misery L; Richard MA; Ortonne JP; Paul C
    J Eur Acad Dermatol Venereol; 2011 May; 25 Suppl 2():19-27. PubMed ID: 21388455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal function and blood pressure in patients treated with cyclosporin A for uveitis.
    Deray G; Le Hoang P; Cacoub P; Aupetit B; Mertani A; Martinez F; Rottembourg J
    Eur J Clin Pharmacol; 1988; 34(6):601-4. PubMed ID: 3169111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of PUVA- and retinoid-PUVA-resistant severe psoriasis with systemic cyclosporin A.
    Takashima A; Morita A; Tsuji T
    J Dermatol; 1990 Aug; 17(8):482-8. PubMed ID: 2229652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral cyclosporin A in the treatment of psoriasis: an overview of studies performed in The Netherlands.
    Meinardi MM; de Rie MA; Bos JD
    Br J Dermatol; 1990 Jun; 122 Suppl 36():27-31. PubMed ID: 2196081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal function and biopsy findings after 5 years' treatment with low-dose cyclosporin for psoriasis.
    Powles AV; Cook T; Hulme B; Baker BS; Lewis HM; Thomas E; Valdimarsson H; Fry L
    Br J Dermatol; 1993 Feb; 128(2):159-65. PubMed ID: 8457449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between lymphocyte cyclosporin sensitivity and clinical progress of psoriasis.
    Umezawa Y; Oh-i T; Koga M
    J Dermatol Sci; 2001 Jun; 26(2):94-9. PubMed ID: 11378324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclosporine maintenance therapy in psoriasis.
    Meinardi MM; Bos JD
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):42-9. PubMed ID: 3381301
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyclosporin A: preliminary results in the treatment of psoriasis.
    Bonifati C; Clerico R; Potenza CM; Carlesimo M
    Acta Derm Venereol Suppl (Stockh); 1989; 146():151-4. PubMed ID: 2532844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose cyclosporine A in severe psoriasis.
    Marks J
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):68-71. PubMed ID: 3381305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does fish oil protect renal function in cyclosporin-treated psoriasis patients?
    Stoof TJ; Korstanje MJ; Bilo HJ; Starink TM; Hulsmans RF; Donker AJ
    J Intern Med; 1989 Dec; 226(6):437-41. PubMed ID: 2489230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psoriasis: immunopathology and long-term treatment with cyclosporin.
    Fry L
    J Autoimmun; 1992 Apr; 5 Suppl A():277-83. PubMed ID: 1503622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Results of cyclosporin treatment of severe, chronic psoriasis vulgaris].
    Engst R; Huber J
    Hautarzt; 1989 Aug; 40(8):486-9. PubMed ID: 2676910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclosporin A serum and blood levels in marrow graft recipients: correlation with administered dose, serum creatinine and graft-versus-host disease.
    Bacigalupo A; Di Giorgio F; Frassoni F; Van Lint MT; Raffo MR; Gogioso L; Viale M; Marmont AM
    Acta Haematol; 1984; 72(3):155-62. PubMed ID: 6438979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term treatment of severe psoriasis with low-dose cyclosporin: (2.5 mg/kg/day to 5 mg/kg/day).
    Frappaz A; Haftek H; Thivolet J
    Acta Derm Venereol Suppl (Stockh); 1989; 146():147. PubMed ID: 2692369
    [No Abstract]   [Full Text] [Related]  

  • 35. Cyclosporin-A deposits in renal allografts.
    von Willebrand E; Häyry P
    Lancet; 1983 Jul; 2(8343):189-92. PubMed ID: 6135029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term treatment of psoriasis with cyclosporin A--side-effects, minimal effective dose and cyclosporin blood levels.
    Korstanje MJ; Van de Staak WJ
    Clin Exp Dermatol; 1991 Jan; 16(1):8-10. PubMed ID: 1902760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term continuous versus intermittent cyclosporin: therapy for psoriasis.
    Ohtsuki M; Nakagawa H; Sugai J; Ozawa A; Ohkido M; Nakayama J; Hanada J; Morimoto Y; Jimbow K; Horikoshi T; Kitahara H; Tamaki K; Urabe K; Hori Y
    J Dermatol; 2003 Apr; 30(4):290-8. PubMed ID: 12707465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal side effects of high and low cyclosporin A doses in patients with rheumatoid arthritis.
    Berg KJ; Førre O; Djøseland O; Mikkelsen M; Narverud J; Rugstad HE
    Clin Nephrol; 1989 May; 31(5):232-8. PubMed ID: 2661065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of cyclosporine on posttransplant blood pressure response.
    Jarowenko MV; Flechner SM; Van Buren CT; Lorber MI; Kahan BD
    Am J Kidney Dis; 1987 Aug; 10(2):98-103. PubMed ID: 3300297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and tolerability of cyclosporin A (Sandimmun) in idiopathic nephrotic syndrome. Collaborative Study Group of Sandimmun in Nephrotic Syndrome.
    Clin Nephrol; 1991; 35 Suppl 1():S48-60. PubMed ID: 1860268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.